Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1

Nature volume 436, pages 290–293 (2005)Cite this article

Abstract

Increased expression of vascular cell adhesion molecule 1 (VCAM1) is associated with a variety of chronic inflammatory conditions, making its expression and function a target for therapeutic intervention1,2,3. We have recently identified CAM741, a derivative of a fungus-derived cyclopeptolide that acts as a selective inhibitor of VCAM1 synthesis in endothelial cells. Here we show that the compound represses the biosynthesis of VCAM1 in cells by blocking the process of cotranslational translocation, which is dependent on the signal peptide of VCAM1. CAM741 does not inhibit targeting of the VCAM1 nascent chains to the translocon channel but prevents translocation to the luminal side of the endoplasmic reticulum (ER), through a process that involves the translocon component Sec61β. Consequently, the VCAM1 precursor protein is synthesized towards the cytosolic compartment of the cells, where it is degraded. Our results indicate that the inhibition of cotranslational translocation with low-molecular-mass compounds, using specificity conferred by signal peptides, can modulate the biosynthesis of certain secreted and/or membrane proteins. In addition, they highlight cotranslational translocation at the ER membrane as a potential target for drug discovery.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: CAM741 dose-dependently inhibits VCAM1 glycoprotein expression in transiently transfected cells.
Figure 2: Overexpressed VCAM1 is degraded by intracellular proteases in the presence of CAM741.
Figure 3: CAM741 dose-dependently inhibits cotranslational translocation of VCAM1.
Figure 4: VCAM1 SP is crucial for conferring cyclopeptolide sensitivity.
Figure 5: CAM741 inhibits VCAM1 translocation at a post-targeting step and enhances interaction of the VCAM1 nascent chains with Sec61β.

Similar content being viewed by others

References

  1. Springer, T. A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57, 827–872 (1995)

    Article  CAS  Google Scholar 

  2. Schreiner, E. P., Oberhauser, B. & Foster, C. A. Inhibitors of vascular cell adhesion molecule-1 expression. Expert Opin. Therapeut. Patents 13, 149–166 (2003)

    Article  CAS  Google Scholar 

  3. Bevilacqua, M. P., Nelson, R. M., Mannori, G. & Cecconi, O. Endothelial-leukocyte adhesion molecules in human disease. Annu. Rev. Med. 45, 361–378 (1994)

    Article  CAS  Google Scholar 

  4. Boger, D. L., Keim, H., Oberhauser, B., Schreiner, E. P. & Foster, C. A. Total synthesis of HUN-7293. J. Am. Chem. Soc. 121, 6197–6205 (1999)

    Article  CAS  Google Scholar 

  5. Hommel, U. et al. The 3D-structure of a natural inhibitor of cell adhesion molecule expression. FEBS Lett. 379, 69–73 (1996)

    Article  ADS  CAS  Google Scholar 

  6. Walter, P. & Johnson, A. E. Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. Annu. Rev. Cell Biol. 10, 87–119 (1994)

    Article  CAS  Google Scholar 

  7. Matlack, K. E., Mothes, W. & Rapoport, T. A. Protein translocation: tunnel vision. Cell 92, 381–390 (1998)

    Article  CAS  Google Scholar 

  8. Johnson, A. E. & van Waes, M. A. The translocon: a dynamic gateway at the ER membrane. Annu. Rev. Cell Dev. Biol. 15, 799–842 (1999)

    Article  Google Scholar 

  9. Jungnickel, B. & Rapoport, T. A. A posttargeting signal sequence recognition event in the endoplasmic reticulum membrane. Cell 82, 261–270 (1995)

    Article  CAS  Google Scholar 

  10. Kim, S. J., Mitra, D., Salerno, J. R. & Hegde, R. S. Signal sequences control gating of the protein translocation channel in a substrate-specific manner. Dev. Cell 2, 207–217 (2002)

    Article  CAS  Google Scholar 

  11. Rutkowski, D. T., Lingappa, V. R. & Hegde, R. S. Substrate-specific regulation of the ribosome–translocon junction by N-terminal signal sequences. Proc. Natl Acad. Sci. USA 98, 7823–7828 (2001)

    Article  ADS  CAS  Google Scholar 

  12. Fons, R. D., Bogert, B. A. & Hegde, R. S. Substrate-specific function of the translocon-associated protein complex during translocation across the ER membrane. J. Cell Biol. 160, 529–539 (2003)

    Article  CAS  Google Scholar 

  13. Mothes, W., Prehn, S. & Rapoport, T. A. Systematic probing of the environment of a translocating secretory protein during translocation through the ER membrane. EMBO J. 13, 3973–3982 (1994)

    Article  CAS  Google Scholar 

  14. Kalies, K. U., Rapoport, T. A. & Hartmann, E. The beta subunit of the Sec61 complex facilitates cotranslational protein transport and interacts with the signal peptidase during translocation. J. Cell Biol. 141, 887–894 (1998)

    Article  CAS  Google Scholar 

  15. DeMartino, G. N. & Slaughter, C. A. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274, 22123–22126 (1999)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank A. Rot for generation of the Sec61β antiserum, H. Jaksche for its purification, and B. Kappel, H. Pertl, L. Hofer and N. Lettner for technical assistance.

Author information

Author notes

  1. Christiane Dascher-Nadel

    Present address: Inserm Transfert SA, 18, avenue Mozart, BP172, F-13276, Marseille Cedex, 09, France

  2. Jürgen Besemer

    Present address: Carl Zwilling Parz-G 1186/1, A-2340, Mödling, Austria

  3. Katharina Marquardt

    Present address: , Vogelsang 7A, D-38118, Braunschweig, Germany

  4. Jürgen Besemer and Hanna Harant: *These authors contributed equally to this work

Authors and Affiliations

  1. Novartis Institutes for BioMedical Research, Brunner Strasse 59, A-1235, Vienna, Austria

    Jürgen Besemer, Hanna Harant, Shirley Wang, Berndt Oberhauser, Katharina Marquardt, Carolyn A. Foster, Erwin P. Schreiner, Jan E. de Vries, Christiane Dascher-Nadel & Ivan J. D. Lindley

Authors
  1. Jürgen Besemer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanna Harant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shirley Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Berndt Oberhauser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Katharina Marquardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carolyn A. Foster
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Erwin P. Schreiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jan E. de Vries
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Christiane Dascher-Nadel
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ivan J. D. Lindley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan E. de Vries.

Ethics declarations

Competing interests

H.H., S.W., C.A.F., E.P.S., B.O., J.E.d.V. and I.J.D.L. are employed by Novartis. In addition, B.O., J.E.d.V. and I.J.D.L. own restricted stocks. J.B., K.M. and C.D.-N. left Novartis and do not have any conflicting financial interests.

Supplementary information

Supplementary Data

Data demonstrating that the VCAM-1 SP plus the first amino acid of the VCAM-1 mature region are required for full sensitivity to CAM741, while parts of the N-terminal region of the VCAM-1 SP are dispensable for translocation and sensitivity. (DOC 24 kb)

Supplementary Figure S1

In vitro translocation experiments described in Supplementary Data. (PDF 225 kb)

Supplementary Figure S1 Legend (DOC 23 kb)

Supplementary Table S1

Results from transient transfection experiments described in Supplementary Data. (DOC 32 kb)

Supplementary Methods

Methods for experiment shown in Supplementary Table S1. (DOC 19 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Besemer, J., Harant, H., Wang, S. et al. Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1. Nature 436, 290–293 (2005). https://doi.org/10.1038/nature03670

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature03670

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing